Suprema, a global leader of AI-powered security solutions, announced that BioStation 3 is expected to set a new annual global sales record by the end of this year. This represents the highest annual sales record for Suprema’s biometric devices and highlights the accelerating global demand for facial authentication solutions.

Importantly, this growth reflects balanced momentum across major regions rather than a temporary spike in a single market. BioStation 3 has achieved more than 30 percent year-over-year sales growth in key markets including the United Kingdom, the Americas, Japan, and the Middle East. In addition, deployments ranging from 600 to over 1,000 units at high-security sites such as public institutions, financial organizations, and large-scale residential complexes have further strengthened its position in the global security market.

Three key factors underpin BioStation 3’s recognized competitiveness worldwide. First, its AI-powered facial authentication delivers high accuracy and stable performance, enabling administrators and end users to experience secure, seamless access authentication in real-world environments. Second, its user experience is optimized for actual operating conditions, enhancing both convenience and security even under diverse environments and complex security requirements. Finally, these strengths are supported by BioStation 3’s robust data protection capabilities. BioStation 3 complies with GDPR, one of the world’s most stringent data protection regulations, and has successfully passed iBeta’s ISO/IEC 30107-3 Presentation Attack Detection (PAD) test for facial spoofing. It also incorporates advanced data protection and encryption technologies, along with Suprema’s innovative Template on Mobile (ToM) authentication method, which allows users to directly manage their own personal data. Building on these strong data protection and privacy capabilities, BioStation 3 has earned a high level of trust in markets such as the United States and the United Kingdom, where adoption of facial authentication has traditionally been more conservative and regulatory requirements are stringent, and it is now being actively deployed in major projects. As a result, broader adoption across a wider range of industry sectors is expected next year.

BioStation 3’s value has been demonstrated not only through its sales performance but also through recognition from industry experts. It received the Best Product award in the Biometrics category at the 2025 Readers’ Choice Awards, hosted by the global security publication Security Buyer magazine. This prestigious award is organized by Security Buyer, a leading media outlet covering global security industry trends and emerging technologies, and is presented to products whose innovationㄴ and market potential have been validated through voting by security professionals.

“The record-breaking sales performance and global award recognition of BioStation 3 demonstrate how AI-powered facial authentication technology is rapidly establishing its presence in the global market. It is particularly meaningful that major international clients with stringent security requirements have recognized the accuracy and reliability of BioStation 3 and adopted it in real-world projects,” said Hanchul Kim, CEO of Suprema Inc. “Suprema will continue to address emerging challenges in the security industry and lead global standards through continuous innovation that enhances both security and convenience.”